GSK to Acquire BELLUS Health for $2 Billion
GSK has entered into an agreement to acquire BELLUS Health, a Canadian late-stage biopharmaceutical company, for a total consideration of
Read more
Respiratory
ReCode Starts Phase 1 Trial of Inhaled Genetic Medicine for PCD
ReCode Therapeutics, announced the dosing of the first participants in a Phase 1 trial designed to evaluate the safety and
Read more
EC Approves Sanofi and Regeneron’s Dupixent® for Eosinophilic Esophagitis
The European Commission has authorised Sanofi and Regeneron’s Dupixent® (dupilumab) as the first and only therapeutic therapy for eosinophilic esophagitis.
Read more
AstraZeneca and Amgen’s TEZSPIRE® Approved for Self-administration in the US
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) for self-administration in a pre-filled, single-use
Read more
International Respiratory Coalition Launches to Improve Post-Pandemic Respiratory Care
The European Respiratory Society (ERS), the Global Allergy and Airways Patient Platform (GAAPP), AstraZeneca, Amgen and leading respiratory clinicians announced
Read more
New analysis proposes Severe COVID-19 is a Microvascular Disease
The range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly
Read more
EU Authorizes Teva’s Seffalair® Spiromax® and BroPair® Spiromax®
Teva Pharmaceuticals Europe reported that Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/fluticasone propionate, 12.75/100 and 12.75/202 micrograms administered
Read more
Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients
The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline
Read more
Reinstated hydroxychloroquine study reveals the dangers of rushed trials
The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to
Read more
Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more